GL1X · GenesisL1 explorer

Research workbench

Selective small molecule inhibitor discovered by chemoproteomic assay platform reveals regulation of TH17 cell differentiation by PI3KGAMMA

Analyse Selective small molecule inhibitor discovered by chemoproteomic assay platform… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4AOF
Type
protein
Length
836 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
EC
2.7.1.153, 2.7.11.1
UniProt
P48736
Ligands
7L0
Pockets
15 · best druggability 0.83

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 12% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (EC 2.7.1.153, 2.7.11.1)protein83640% helix, 12% strandP48736

Ligands and binding sites

  • 7L0 · N-[6-(5-methylsulfonylpyridin-3-yl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl]ethanamide · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

15 pockets found on a 1 Å grid, 8 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19740.830.8484empty
2850.720.9526empty
3660.710.9723empty
43620.670.8132empty
54010.660.79377L0

Compared structures

  • 4AOF · Selective small molecule inhibitor discovered by chemoproteomic assay platform reveals… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.